Stay updated on TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-06T22:07:05.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The study record page now displays a 403 Forbidden error, indicating restricted access to the content. The page shows a minimal error layout with a 403 message and a Home link, preventing access to the trial details.
    Difference
    0.5%
    Check dated 2026-09-29T22:10:29.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page, replacing the study details with an access error. This indicates a viewing restriction or server issue that prevents accessing the study record.
    Difference
    18%
    Check dated 2026-09-22T22:55:24.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The page revision has been updated to v3.7.0, indicating a backend/page template update rather than changes to the study information.
    Difference
    0.1%
    Check dated 2026-09-15T20:49:44.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Multiple myeloma is now listed as the study condition, and a related topics section has been added featuring MedlinePlus Genetics. This enhances the disease context and provides quick access to related information for researchers and participants.
    Difference
    0.2%
    Check dated 2026-09-08T19:38:26.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.5 to v3.6.6. This indicates a minor backend/documentation update.
    Difference
    0.1%
    Check dated 2026-09-01T20:04:10.000Z thumbnail image

Stay in the know with updates to TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial page.